Karyopharm Therapeutics, Inc. (KPTI)
8.99
-0.12
(-1.32%)
USD |
NASDAQ |
Jun 11, 16:00
9.45
+0.46
(+5.12%)
After-Hours: 19:13
Karyopharm Therapeutics Market Cap : 202.67M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 205.38M |
| June 09, 2026 | 195.91M |
| June 08, 2026 | 191.62M |
| June 05, 2026 | 204.70M |
| June 04, 2026 | 204.47M |
| June 03, 2026 | 202.90M |
| June 02, 2026 | 208.08M |
| June 01, 2026 | 221.38M |
| May 29, 2026 | 205.15M |
| May 28, 2026 | 205.38M |
| May 27, 2026 | 203.51M |
| May 26, 2026 | 203.29M |
| May 22, 2026 | 184.93M |
| May 21, 2026 | 182.66M |
| May 20, 2026 | 180.85M |
| May 19, 2026 | 169.29M |
| May 18, 2026 | 161.81M |
| May 15, 2026 | 173.82M |
| May 14, 2026 | 201.70M |
| May 13, 2026 | 200.57M |
| May 12, 2026 | 202.04M |
| May 11, 2026 | 199.66M |
| May 08, 2026 | 194.84M |
| May 07, 2026 | 199.58M |
| May 06, 2026 | 203.41M |
| Date | Value |
|---|---|
| May 05, 2026 | 212.21M |
| May 04, 2026 | 209.73M |
| May 01, 2026 | 197.77M |
| April 30, 2026 | 187.40M |
| April 29, 2026 | 189.43M |
| April 28, 2026 | 157.76M |
| April 27, 2026 | 158.86M |
| April 24, 2026 | 158.86M |
| April 23, 2026 | 160.51M |
| April 22, 2026 | 175.19M |
| April 21, 2026 | 168.21M |
| April 20, 2026 | 164.00M |
| April 17, 2026 | 157.94M |
| April 16, 2026 | 158.86M |
| April 15, 2026 | 157.02M |
| April 14, 2026 | 155.01M |
| April 13, 2026 | 151.89M |
| April 10, 2026 | 146.75M |
| April 09, 2026 | 149.69M |
| April 08, 2026 | 132.99M |
| April 07, 2026 | 132.26M |
| April 06, 2026 | 115.93M |
| April 02, 2026 | 108.05M |
| April 01, 2026 | 106.76M |
| March 31, 2026 | 102.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 156.32B |
| Catalyst Pharmaceuticals, Inc. | 3.832B |
| Incyte Corp. | 21.56B |
| Inovio Pharmaceuticals, Inc. | 77.10M |
| Cellectar Biosciences, Inc. | 9.667M |
Market Cap Related Metrics
| PS Ratio | 0.8910 |
| PEG Ratio | -0.0050 |
| Price | 8.99 |
| Earnings Yield | -167.8% |
| PEGY Ratio | -0.0050 |